From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development

We often hear headlines about breakthrough discoveries and promising new therapies for herpes — only to hear nothing more about them months or even years later. Why do so manyContinue reading "From Discovery to Cure: Understanding the Complex Path of Antiherpetic Drug Development"

🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨

There’s major progress happening in the fight against HSV-2. Assembly Biosciences (ASMB) has reported very promising interim results from two Phase 1b clinical studies testing their new investigational treatments forContinue reading "🚨 Big News in Herpes Research: Promising Phase 1b Results from Assembly Biosciences 🚨"

 Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition

Herpes Cure Advocacy is advocating to make the neonatal herpes infection reportable via a recommendation from the Committee of State and Territorial Epidemiologists (CSTE). Neonatal herpes is a rare disease thatContinue reading " Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition"

Herpes Cure Advocacy Attends the 2025 STI & HIV World Congress

Montréal, Canada This year, members of Herpes Cure Advocacy attended the STI & HIV World Congress in Montréal, Canada — a global gathering of researchers, clinicians, public health leaders, andContinue reading "Herpes Cure Advocacy Attends the 2025 STI & HIV World Congress"

2025 Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk

Liu Y, Johnston C, Jarousse N, et al Association between herpes simplex virus type 1 and the risk of Alzheimer’s disease: a retrospective case–control study BMJ Open 2025;15:e093946. doi: 10.1136/bmjopen-2024-093946 Here are our key takeaways from the studyContinue reading "2025 Gilead-Funded Study Supports Hypothesis that HSV-1 Significantly Increases Alzheimer’s Disease Risk"